Triple-negative breast cancer (TNBC)

Represents a challenge clinically due to the lack of actionable targets coupled with an aggressive disease course and a worse prognosis compared to other breast cancer subtypes.

Book Content

This book covers aspects of TNBC ranging from epidemiology, biology, molecular classification, to currently available and potentially new therapeutic options for TNBC.

Resources Included

This book contains a range of recommended resources, including recent reviews, schematic illustrations, and information for patients with TNBC.

Intended Audience

Individuals including researchers and educators, practitioners, pharmaceutical professionals, patients as well as their family members will find this book useful.